PNC Financial Services Group
ZBIO

PNC Financial Services Group’s Zenas BioPharma ZBIO Stock Holding History

PNC Financial Services Group’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.2K Sell
4,767
-1,057
-18% -$23.7K ﹤0.01% 2861
2025
Q4 		$211K Sell
5,824
-19
-0.3% -$625 ﹤0.01% 2271
2025
Q3 		$130K Sell
5,843
-3,336
-36% -$54.3K ﹤0.01% 2619
2025
Q2 		$88.9K Buy
9,179
+2,679
+41% +$26.1K ﹤0.01% 2789
2025
Q1 		$51.4K Buy
6,500
+83
+1% +$649 ﹤0.01% 3075
2024
Q4 		$52.6K Buy
6,417
+2,568
+67% +$40.1K ﹤0.01% 3076
2024
Q3 		$65.1K Buy
+3,849
New +$69.2K ﹤0.01% 2934

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

PNC Financial Services Group's ZBIO Position: Q1 2026 in Review

PNC Financial Services Group reduced its Zenas BioPharma (ZBIO) stake by 18% in Q1 2026, selling an estimated $23.7K and leaving 4,767 shares worth $93.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2861.

PNC Financial Services Group first reported a position in ZBIO in Q3 2024 and has held it in 7 quarters since. The position peaked at $211K in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • PNC Financial Services Group held 4,767 shares of Zenas BioPharma worth $93.2K as of Q1 2026.
  • PNC Financial Services Group sold 1,057 Zenas BioPharma shares in Q1 2026, an estimated $23.7K.
  • Zenas BioPharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2861 holding.
  • PNC Financial Services Group first reported a position in Zenas BioPharma in Q3 2024 and has held it in 7 quarters since.
  • PNC Financial Services Group's Zenas BioPharma position peaked at $211K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.